The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation

BACKGROUND: The neural transcription factor SOX11 has been described as a prognostic marker in epithelial ovarian cancers (EOC), however its role in individual histological subtypes and tumour grade requires further clarification. Furthermore, methylation-dependent silencing of SOX11 has been report...

Descripción completa

Detalles Bibliográficos
Autores principales: Sernbo, Sandra, Gustavsson, Elin, Brennan, Donal J, Gallagher, William M, Rexhepaj, Elton, Rydnert, Frida, Jirström, Karin, Borrebaeck, Carl AK, Ek, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187763/
https://www.ncbi.nlm.nih.gov/pubmed/21943380
http://dx.doi.org/10.1186/1471-2407-11-405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187763/
https://www.ncbi.nlm.nih.gov/pubmed/21943380
http://dx.doi.org/10.1186/1471-2407-11-405

Ejemplares similares